Verona Pharma PLC Holding(s) in Company (4069V)
April 15 2016 - 11:08AM
UK Regulatory
TIDMVRP TIDMAV.
RNS Number : 4069V
Verona Pharma PLC
15 April 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Verona Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------------- ---------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
-------------------------------------------------------------------- ------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
-------------------------------------------------------------------- ------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
-------------------------------------------------------------------- ------------------------------------------
An event changing the breakdown of voting rights
-------------------------------------------------------------------- ------------------------------------------
Other (please
specify):
----------------------------------------------------------- ------- ------------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- -------------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
BNY Norwich Union Nominees
Limited 4,565,531*
Chase (GA Group) Nominees
Limited 139,363,819*
Available on request 124,125*
*denotes direct interest
Chase (GA Group) Nominees
Limited 15,153,796
Chase Nominees Limited 3,872,597
Vidacos Nominees Limited 18,701,411
------------------------------------------------------------- -------------------------------------------------
5. Date of the transaction 14 April 2016
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- -------------------------------------------------
6. Date on which issuer 15 April 2016
notified:
------------------------------------------------------------- -------------------------------------------------
7. Threshold(s) that is/are 18% to 17% Change at Combined
crossed or Interest Level
reached: (vi, vii)
------------------------------------------------------------- -------------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
---------------- ------------------------------ ------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
---------------- ---------------- ------------ ------------- ------------------------- ------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
---------------- ---------------- ------------ ------------- ------------ ----------- ------- ---------
Ordinary
Shares
GB00B06GSH43 182,250,000 182,250,000 181,781,279 144,053,475 37,727,804 14.26% 3.73%
---------------- ------------ ------------- ------------ ----------- ------- ---------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
---------------- ---------------- --------------------------- ------------------------- ------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
181,781,279 17.99%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited and Friends Provident
International Limited, with the following chain of controlled
undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Life Holdings UK Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Friends Life FPG Limited (wholly owned subsidiary of
Aviva Life Holdings UK Limited)
* Friends Life FPL Limited (wholly owned subsidiary of
Friends Life FPG Limited)
* Friends Life Limited (wholly owned subsidiary of
Friends Life FPL Limited)
* Friends Life and Pensions Limited (wholly owned
subsidiary of Friends Life Limited)
* Friends Provident International Limited (wholly owned
subsidiary of Friends Life and Pensions Limited)
Proxy Voting:
(MORE TO FOLLOW) Dow Jones Newswires
April 15, 2016 11:08 ET (15:08 GMT)
-----------------------------------------------------------------
10. Name of the proxy holder: See Section 4
---------------------------------------------- -----------------
11. Number of voting rights proxy
holder will cease
to hold:
---------------------------------------------- -----------------
12. Date on which proxy holder will
cease to hold
voting rights:
---------------------------------------------- -----------------
Figures are based on a total
13. Additional information: number of voting rights of
1,009,923,481, as per the
Company's Result of General
Meeting Announcement of 24
March 2014.
------------------------------- ------------------------------
14. Contact name: Neil Whittaker, Aviva plc
------------------------------- ------------------------------
15. Contact telephone number: 01603 684420
------------------------------- ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGUCUCUPQGAA
(END) Dow Jones Newswires
April 15, 2016 11:08 ET (15:08 GMT)
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jul 2023 to Jul 2024